Clinical Scorecard: Exploring the New Role of Glial Cell Diversity in Neuropathic Pain: Insights into Mechanisms and Treatment Options
At a Glance
Category
Detail
Condition
Key Mechanisms
Involvement of glial cell heterogeneity, including microglia and astrocytes, in neuroinflammatory processes and pain modulation, emphasizing their roles in both initiation and maintenance of neuropathic pain.
Target Population
Care Setting
Key Highlights
Neuropathic pain is characterized by pain from non-noxious stimuli and spontaneous severe pain episodes.
Glial cells play an active role in the initiation and maintenance of neuropathic pain.
Emerging therapeutic strategies target specific glial subpopulations and their activation states, highlighting the importance of glial heterogeneity.
Guideline-Based Recommendations
Diagnosis
Management
Consider targeting distinct glial subpopulations or their activation states for treatment, including specific therapies like P2X4 receptor antagonists and NF-κB inhibitors.
Monitoring & Follow-up
Risks
Patient & Prescribing Data
Therapies may include P2X4 receptor antagonists and NF-κB inhibitors, which target specific glial activation states.
Clinical Best Practices
Utilize a glia-centric approach to understand and treat neuropathic pain.
Incorporate insights from single-cell and spatial transcriptomic profiling in therapeutic strategies, focusing on their application in clinical settings.
A small observational study in collegiate football players found microbiome associations after nonconcussive head impacts, though findings were limited by severe underpowering and high attrition
